Valley National Advisers’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.39K | Hold |
147
| – | – | ﹤0.01% | 842 |
|
|
2026
Q1 | $1K | Buy |
+147
| New | +$1.33K | ﹤0.01% | 840 |
|
|
2025
Q4 | – | Sell |
-787
| Closed | -$6K | – | 933 |
|
|
2025
Q3 | $6K | Buy |
787
+390
| +98% | +$3.04K | ﹤0.01% | 635 |
|
|
2025
Q2 | $2K | Buy |
+397
| New | +$2.63K | ﹤0.01% | 732 |
|
|
2025
Q1 | – | Sell |
-147
| Closed | -$1K | – | 832 |
|
|
2024
Q4 | $1K | Hold |
147
| – | – | ﹤0.01% | 740 |
|
|
2024
Q3 | $1K | Hold |
147
| – | – | ﹤0.01% | 710 |
|
|
2024
Q2 | $1K | Buy |
+147
| New | +$1.48K | ﹤0.01% | 1087 |
|
|
2024
Q1 | – | Sell |
-237
| Closed | -$1K | – | 1271 |
|
|
2023
Q4 | $1K | Hold |
237
| – | – | ﹤0.01% | 1107 |
|
|
2023
Q3 | $2K | Hold |
237
| – | – | ﹤0.01% | 841 |
|
|
2023
Q2 | $2K | Hold |
237
| – | – | ﹤0.01% | 804 |
|
|
2023
Q1 | $2K | Buy |
237
+37
| +19% | +$340 | ﹤0.01% | 772 |
|
|
2022
Q4 | $2K | Sell |
200
-37
| -16% | -$653 | ﹤0.01% | 747 |
|
|
2022
Q3 | $4K | Sell |
237
-75
| -24% | -$3.25K | ﹤0.01% | 714 |
|
|
2022
Q2 | $23K | Hold |
312
| – | – | ﹤0.01% | 455 |
|
|
2022
Q1 | $23K | Hold |
312
| – | – | ﹤0.01% | 485 |
|
|
2021
Q4 | $45K | Sell |
312
-80
| -20% | -$13.7K | 0.01% | 376 |
|
|
2021
Q3 | $81K | Hold |
392
| – | – | 0.01% | 300 |
|
|
2021
Q2 | $83K | Buy |
392
+80
| +26% | +$14.7K | 0.02% | 299 |
|
|
2021
Q1 | $57K | Hold |
312
| – | – | 0.01% | 321 |
|
|
2020
Q4 | $35K | Buy |
312
+90
| +41% | +$9.57K | 0.01% | 354 |
|
|
2020
Q3 | $24K | Sell |
222
-515
| -70% | -$62.7K | 0.01% | 380 |
|
|
2020
Q2 | $61K | Buy |
737
+252
| +52% | +$9.64K | 0.01% | 278 |
|
|
2020
Q1 | $7K | Hold |
485
| – | – | ﹤0.01% | 509 |
|
|
2019
Q4 | $2K | Hold |
485
| – | – | ﹤0.01% | 687 |
|
|
2019
Q3 | $2K | Hold |
485
| – | – | ﹤0.01% | 688 |
|
|
2019
Q2 | $3K | Sell |
485
-100
| -17% | -$787 | ﹤0.01% | 609 |
|
|
2019
Q1 | $6K | Hold |
585
| – | – | ﹤0.01% | 539 |
|
|
2018
Q4 | $22K | Buy |
585
+560
| +2,240% | +$21.7K | 0.01% | 350 |
|
|
2018
Q3 | $1K | Hold |
25
| – | – | ﹤0.01% | 644 |
|
|
2018
Q2 | $1K | Hold |
25
| – | – | ﹤0.01% | 627 |
|
|
2018
Q1 | $1K | Hold |
25
| – | – | ﹤0.01% | 604 |
|
|
2017
Q4 | $1K | Hold |
25
| – | – | ﹤0.01% | 619 |
|
|
2017
Q3 | $1K | Hold |
25
| – | – | ﹤0.01% | 616 |
|
|
2017
Q2 | $1K | Hold |
25
| – | – | ﹤0.01% | 569 |
|
|
2017
Q1 | $1K | Hold |
25
| – | – | ﹤0.01% | 574 |
|
|
2016
Q4 | $1K | Hold |
25
| – | – | ﹤0.01% | 610 |
|
|
2016
Q3 | $1K | Hold |
25
| – | – | ﹤0.01% | 597 |
|
|
2016
Q2 | $4K | Hold |
25
| – | – | ﹤0.01% | 472 |
|
|
2016
Q1 | $3K | Hold |
25
| – | – | ﹤0.01% | 498 |
|
|
2015
Q4 | $4K | Buy |
+25
| New | +$3.85K | ﹤0.01% | 471 |
|
Other funds holding NVAX
SCM
S
Valley National Advisers's NVAX Position: Q2 2026 in Review
Valley National Advisers held its Novavax (NVAX) position steady in Q2 2026 at 147 shares worth $1.39K. The position accounts for ﹤0.01% of the portfolio, ranked #842.
Valley National Advisers first reported a position in NVAX in Q4 2015 and has held it in 40 quarters since. The position peaked at $83K in Q2 2021. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.
- Valley National Advisers held 147 shares of Novavax worth $1.39K as of Q2 2026.
- Valley National Advisers left its Novavax share count unchanged in Q2 2026.
- Novavax made up ﹤0.01% of Valley National Advisers's portfolio in Q2 2026, its #842 holding.
- Valley National Advisers first reported a position in Novavax in Q4 2015 and has held it in 40 quarters since.
- Valley National Advisers's Novavax position peaked at $83K in Q2 2021.
- 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.
Based on Valley National Advisers's 13F filing for Q2 2026, filed 29 Jul 2026.